Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.
Here are some groups and programs to help ease the transition from treatment to survivorship.
The NCI stands to lose nearly $900 million, but childhood cancer would see an increase.
NCI is expanding eligibility criteria for its cancer clinical trials in the hope that more people will enroll.
Multipronged approach eliminated treatment gaps between black and white patients and improved overall treatment rates.
National Institutes of Health scientists use epigenetics to help predict disease development.
Scientists seek to design clinical trials to test therapies that are tailored to the specific genetic drivers of rare tumors.
Overall, the therapy worked very well in the mice used in the study. The first human clinical trial will be in adult brain cancers.
The Human Tumor Atlas Network initiative will create maps of human tumors and their surrounding environment.
The cost of treating complications of invasive diagnostic procedures can be substantial.
Experts say the regimen will become the standard of care for people up to age 40 who are newly diagnosed with acute lymphoblastic leukemia.
“More of these studies are needed to make progress in…precision, or personalized, medicine,” said NCI’s Konstantin Salnikow, PhD.
But, despite the difference, the risk of dying from the disease is still small.
Researchers are learning new ways to manage common types of cancer pain, like bone pain and neuropathy pain.
Worldwide, more than 21 million new cases of cancer are predicted to occur in 2030.
An interview with researcher Mario Suvà, MD, PhD
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.